Literature DB >> 18683009

Pancreaticoduodenectomy with vascular resection for local advanced pancreatic head cancer: a single center retrospective study.

Chunyou Wang1, Heshui Wu, Jiongxin Xiong, Feng Zhou, Jing Tao, Tao Liu, Gang Zhao, Shanmiao Gou.   

Abstract

INTRODUCTION: Pancreaticoduodenectomy with vascular resection remains a controversial approach for patients with local advanced pancreatic head cancer for the lack of evidences of survival and quality of life benefits. The aim of this study was to evaluate whether patients of pancreatic head cancer benefit on quality of life, survival, and treatment cost from pancreaticoduodenectomy with vascular resection compared with palliative therapy.
MATERIALS AND METHODS: Two hundred fourteen patients of pancreatic head cancer whose pancreatic head could not be dissected free from adjacent vascular were involved in this study. Eighty of these patients underwent pancreaticoduodenectomy with vascular resection, whereas other patients underwent palliative therapy.
RESULTS: Pancreaticoduodenectomy with artery resection offered worse outcomes on almost all aspects of quality of life and survival compared with palliative therapy. Pancreaticoduodenectomy with vein resection offered better 5-year survival compared with palliative therapy, whereas palliative therapy offered better quality of life after surgery.
CONCLUSION: Pancreaticoduodenectomy with artery resection is nonsensical on treatment of pancreatic head cancer with artery adhesion/invasion. As for patients with vein adhesion/invasion, pancreaticoduodenectomy with vein resection should be performed cautiously. When actual vein invasion is very possible to have taken place, the choice of treatment strategy should be considered carefully by the pancreatic surgeons.

Entities:  

Mesh:

Year:  2008        PMID: 18683009     DOI: 10.1007/s11605-008-0621-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

Review 1.  Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?

Authors:  P Bachellier; H Nakano; P D Oussoultzoglou; J C Weber; K Boudjema; P D Wolf; D Jaeck
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

Review 2.  Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.

Authors:  Margaret Tempero; J Pablo Arnoletti; Edgar Ben-Josef; Pankaj Bhargava; Ephraim S Casper; Paula Kim; Mokenge P Malafa; Eric K Nakakura; Stephen Shibata; Mark Talamonti; Hanlin Wang; Christopher Willett
Journal:  J Natl Compr Canc Netw       Date:  2007-11       Impact factor: 11.908

Review 3.  Pancreatic carcinoma.

Authors:  A L Warshaw; C Fernández-del Castillo
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

6.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Authors:  Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

7.  Current practice patterns in pancreatic surgery: results of a multi-institutional analysis of seven large surgical departments in Germany with 1454 pancreatic head resections, 1999 to 2004 (German Advanced Surgical Treatment study group).

Authors:  Frank Makowiec; Stefan Post; Hans-Detlev Saeger; Norbert Senninger; Heinz Becker; Michael Betzler; Heinz J Buhr; Ulrich T Hopt
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

8.  Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT.

Authors:  E M Loyer; C L David; R A Dubrow; D B Evans; C Charnsangavej
Journal:  Abdom Imaging       Date:  1996 May-Jun

9.  Clinical significance of portal invasion by pancreatic head carcinoma.

Authors:  A Nakao; A Harada; T Nonami; T Kaneko; S Inoue; H Takagi
Journal:  Surgery       Date:  1995-01       Impact factor: 3.982

Review 10.  Extended resection for pancreatic adenocarcinoma.

Authors:  Srinevas K Reddy; Douglas S Tyler; Theodore N Pappas; Bryan M Clary
Journal:  Oncologist       Date:  2007-06
View more
  13 in total

Review 1.  Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review.

Authors:  Terence C Chua; Akshat Saxena
Journal:  J Gastrointest Surg       Date:  2010-04-09       Impact factor: 3.452

2.  An Improved Staging System for Locally Advanced Pancreatic Cancer: A Critical Need in the Multidisciplinary Era.

Authors:  Marc W Fromer; Jenci Hawthorne; Prejesh Philips; Michael E Egger; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2021-06-04       Impact factor: 5.344

Review 3.  Beyond the whipple operation: radical resections for cancers of the head of the pancreas.

Authors:  Hans F Schoellhammer; Bryan S Goldner; Joseph Kim; Gagandeep Singh
Journal:  Indian J Surg Oncol       Date:  2013-07-17

4.  Implantation of radioactive (125)I seeds improves the prognosis of locally advanced pancreatic cancer patients: A retrospective study.

Authors:  Yong-Feng Li; Zhi-Qiang Liu; Yu-Shun Zhang; Li-Ming Dong; Chun-You Wang; Shan-Miao Gou; He-Shui Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

5.  Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer.

Authors:  Masaru Miyazaki; Hideyuki Yoshitomi; Shigetsugu Takano; Hiroaki Shimizu; Atsushi Kato; Hiroyuki Yoshidome; Katunori Furukawa; Tsukasa Takayashiki; Satoshi Kuboki; Daisuke Suzuki; Nozomu Sakai; Masayuki Ohtuka
Journal:  Langenbecks Arch Surg       Date:  2017-03-30       Impact factor: 3.445

6.  Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer.

Authors:  Hryhoriy Lapshyn; Peter Bronsert; Louisa Bolm; Martin Werner; Ulrich T Hopt; Frank Makowiec; Uwe A Wittel; Tobias Keck; Ulrich F Wellner; Dirk Bausch
Journal:  Langenbecks Arch Surg       Date:  2016-01-06       Impact factor: 3.445

7.  Prosthetic graft for superior mesenteric-portal vein reconstruction in pancreaticoduodenectomy: a retrospective, multicenter study.

Authors:  Kai Liao; Huaizhi Wang; Qilong Chen; Zheng Wu; Leida Zhang
Journal:  J Gastrointest Surg       Date:  2014-06-11       Impact factor: 3.452

8.  Indication for the use of an interposed graft during portal vein and/or superior mesenteric vein reconstruction in pancreatic resection based on perioperative outcomes.

Authors:  Seiko Hirono; Manabu Kawai; Masaji Tani; Ken-Ichi Okada; Motoki Miyazawa; Atsushi Shimizu; Yuji Kitahata; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2014-03-25       Impact factor: 3.445

9.  Low concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer action.

Authors:  Shanmiao Gou; Pengfei Cui; Xiangsheng Li; Pengfei Shi; Tao Liu; Chunyou Wang
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

Review 10.  Current State of Vascular Resections in Pancreatic Cancer Surgery.

Authors:  Thilo Hackert; Lutz Schneider; Markus W Büchler
Journal:  Gastroenterol Res Pract       Date:  2015-11-02       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.